Skip to main content

Table 1 Baseline characteristics of participants

From: Effects of N-acetylcysteine on the expressions of UCP1 and factors related to thyroid function in visceral adipose tissue of obese adults: a randomized, double-blind clinical trial

Variables

Groups, mean (SD)

P-valuea

NAC (n = 22)

Control (n = 21)

Age, y

41.09(5.25)

40.18(6.32)

0.598

Female (n, %)

12 (54.5)

11 (52.3)

0.609

Weight (kg)

125.02(12.12)

126.88(11.60)

0.810

BMI (kg/m2)

44.36(3.04)

44.03(4.09)

0.609

Waist-circumference (cm)

137.55(11.07)

136.27 (10.39)

0.936

FT3 (pmol/L)

4.47 (0.59)

4.51(0.57)

0.825

FT4 (pmol/L)

14.82(1.29)

14.87 (1.12)

0.894

TSH (mIU/L)

2.23(0.49)

2.35(0.66)

0.547

Physical Activity (met.h/wk)

1221.00(651.03)

1199.91(741.21)

0.981

Multivitamin use (n, %)

6(27.2)

6(28.5)

0.990

Drug use (n, %)

9 (40.9)

10 (47.6)

0.498

  1. a Data obtained from independent sample T-Test for continuous variables and Chi-square for categorical variables
  2. Abbreviations: NAC: N-Acetylcysteine, BMI: Body mass index, FBS: Fasting blood sugar, HDL-C: High density lipoprotein-cholesterol, HOMA_IR: Homeostatic model assessment-insulin resistance, LDL-C: Low density lipoprotein-cholesterol; TC: Total cholesterol, TG: Triglycerides, WC: Waist circumference, hs-CRP: high-sensitivity C-reactive protein